| immune effector process | GO:0002252 | 321 | 0.499 | |
| non canonical wnt signaling pathway | GO:0035567 | 33 | 0.401 | |
| negative regulation of synaptic vesicle transport | GO:1902804 | 3 | 0.373 | |
| membrane fusion | GO:0061025 | 38 | 0.355 | |
| organelle fusion | GO:0048284 | 28 | 0.323 | |
| regulation of secretion by cell | GO:1903530 | 249 | 0.279 | Human |
| purine ribonucleoside triphosphate metabolic process | GO:0009205 | 220 | 0.241 | |
| negative regulation of calcium ion dependent exocytosis | GO:0045955 | 3 | 0.224 | |
| protein processing | GO:0016485 | 163 | 0.224 | |
| regulation of exocytosis | GO:0017157 | 61 | 0.217 | Human |
| rap protein signal transduction | GO:0032486 | 3 | 0.205 | |
| positive regulation of cell death | GO:0010942 | 224 | 0.193 | |
| purine nucleoside metabolic process | GO:0042278 | 241 | 0.181 | |
| purine containing compound metabolic process | GO:0072521 | 311 | 0.178 | |
| nucleotide catabolic process | GO:0009166 | 217 | 0.178 | |
| actin polymerization or depolymerization | GO:0008154 | 54 | 0.169 | |
| microtubule based movement | GO:0007018 | 84 | 0.168 | |
| amine metabolic process | GO:0009308 | 45 | 0.163 | |
| barbed end actin filament capping | GO:0051016 | 6 | 0.162 | |
| nucleoside phosphate catabolic process | GO:1901292 | 222 | 0.161 | |
| wnt signaling pathway planar cell polarity pathway | GO:0060071 | 27 | 0.160 | |
| purine ribonucleotide catabolic process | GO:0009154 | 208 | 0.158 | |
| hormone secretion | GO:0046879 | 128 | 0.157 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 66 | 0.154 | |
| nucleoside phosphate metabolic process | GO:0006753 | 338 | 0.152 | |
| vacuole organization | GO:0007033 | 38 | 0.152 | |
| arp2 3 complex mediated actin nucleation | GO:0034314 | 3 | 0.151 | |
| establishment of tissue polarity | GO:0007164 | 28 | 0.150 | |
| amide transport | GO:0042886 | 138 | 0.149 | |
| leukocyte mediated immunity | GO:0002443 | 174 | 0.145 | |
| regulation of actin cytoskeleton organization | GO:0032956 | 84 | 0.143 | |
| purine ribonucleoside metabolic process | GO:0046128 | 241 | 0.141 | |
| cytoplasmic transport | GO:0016482 | 234 | 0.139 | |
| insulin secretion | GO:0030073 | 89 | 0.135 | |
| purine nucleoside triphosphate metabolic process | GO:0009144 | 226 | 0.134 | |
| receptor localization to synapse | GO:0097120 | 4 | 0.133 | |
| purine nucleoside triphosphate catabolic process | GO:0009146 | 203 | 0.132 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 5 | 0.132 | |
| establishment of vesicle localization | GO:0051650 | 81 | 0.130 | |
| regulation of secretion | GO:0051046 | 274 | 0.128 | Human |
| regulation of cell shape | GO:0008360 | 39 | 0.123 | |
| organophosphate catabolic process | GO:0046434 | 232 | 0.123 | |
| glycosyl compound metabolic process | GO:1901657 | 246 | 0.119 | |
| nucleoside triphosphate metabolic process | GO:0009141 | 230 | 0.118 | |
| vesicle fusion | GO:0006906 | 16 | 0.117 | |
| nucleoside metabolic process | GO:0009116 | 246 | 0.117 | |
| regulation of cellular amine metabolic process | GO:0033238 | 20 | 0.110 | |
| neurotransmitter secretion | GO:0007269 | 62 | 0.110 | |
| regulation of protein transport | GO:0051223 | 163 | 0.108 | |
| positive regulation of cell adhesion | GO:0045785 | 80 | 0.107 | |
| cellular protein complex assembly | GO:0043623 | 116 | 0.106 | |
| establishment of synaptic vesicle localization | GO:0097480 | 57 | 0.105 | |
| synaptic vesicle localization | GO:0097479 | 59 | 0.104 | |
| ribonucleoside monophosphate catabolic process | GO:0009158 | 57 | 0.103 | |
| negative regulation of exocytosis | GO:0045920 | 12 | 0.102 | |
| negative regulation of secretion | GO:0051048 | 61 | 0.102 | |
| regulation of protein localization | GO:0032880 | 231 | 0.101 | |
| calcium ion dependent exocytosis | GO:0017156 | 35 | 0.101 | |
| negative regulation of actin filament depolymerization | GO:0030835 | 9 | 0.099 | |
| cellular amine metabolic process | GO:0044106 | 44 | 0.097 | |
| positive regulation of peptide hormone secretion | GO:0090277 | 31 | 0.092 | |
| positive regulation of programmed cell death | GO:0043068 | 218 | 0.090 | |
| nucleobase containing small molecule metabolic process | GO:0055086 | 352 | 0.090 | |
| membrane organization | GO:0061024 | 245 | 0.087 | |
| lymphocyte mediated immunity | GO:0002449 | 139 | 0.087 | |
| regulation of homeostatic process | GO:0032844 | 182 | 0.087 | |
| blood vessel morphogenesis | GO:0048514 | 285 | 0.086 | |
| regulation of actin polymerization or depolymerization | GO:0008064 | 45 | 0.086 | |
| regulation of establishment of protein localization | GO:0070201 | 181 | 0.085 | |
| purine ribonucleoside catabolic process | GO:0046130 | 205 | 0.084 | |
| purine containing compound catabolic process | GO:0072523 | 213 | 0.084 | |
| synaptic vesicle transport | GO:0048489 | 57 | 0.083 | |
| regulation of vacuole organization | GO:0044088 | 4 | 0.081 | |
| actin filament organization | GO:0007015 | 113 | 0.079 | |
| regulation of lamellipodium assembly | GO:0010591 | 3 | 0.079 | |
| peptide secretion | GO:0002790 | 114 | 0.079 | |
| negative regulation of secretion by cell | GO:1903531 | 54 | 0.077 | |
| organelle localization | GO:0051640 | 179 | 0.077 | |
| positive regulation of neuron projection development | GO:0010976 | 79 | 0.076 | |
| regulation of angiotensin levels in blood | GO:0002002 | 4 | 0.076 | |
| organonitrogen compound catabolic process | GO:1901565 | 264 | 0.076 | |
| positive regulation of metalloenzyme activity | GO:0048554 | 3 | 0.076 | |
| intracellular protein transport | GO:0006886 | 204 | 0.075 | |
| regulation of cytoskeleton organization | GO:0051493 | 122 | 0.075 | |
| ribonucleoside triphosphate catabolic process | GO:0009203 | 199 | 0.075 | |
| establishment or maintenance of cytoskeleton polarity | GO:0030952 | 2 | 0.075 | |
| single organism cell adhesion | GO:0098602 | 156 | 0.074 | |
| cation transport | GO:0006812 | 399 | 0.073 | |
| glycosyl compound catabolic process | GO:1901658 | 206 | 0.073 | |
| regulation of endocytic recycling | GO:2001135 | 3 | 0.072 | |
| leukocyte apoptotic process | GO:0071887 | 71 | 0.071 | |
| nucleotide metabolic process | GO:0009117 | 332 | 0.069 | |
| regulation of cell adhesion | GO:0030155 | 154 | 0.067 | |
| t cell mediated immunity | GO:0002456 | 50 | 0.066 | |
| establishment of organelle localization | GO:0051656 | 122 | 0.066 | |
| exocytosis | GO:0006887 | 121 | 0.066 | Human |
| cellular nitrogen compound catabolic process | GO:0044270 | 280 | 0.066 | |
| positive regulation of protein autophosphorylation | GO:0031954 | 4 | 0.066 | |
| regulation of hormone levels | GO:0010817 | 211 | 0.065 | |
| positive regulation of cellular amine metabolic process | GO:0033240 | 5 | 0.065 | |
| angiogenesis | GO:0001525 | 201 | 0.064 | |
| negative regulation of lymphocyte apoptotic process | GO:0070229 | 24 | 0.064 | |
| positive regulation of secretion by cell | GO:1903532 | 114 | 0.064 | Human |
| ribonucleotide catabolic process | GO:0009261 | 208 | 0.063 | |
| aromatic compound catabolic process | GO:0019439 | 286 | 0.063 | |
| pigmentation | GO:0043473 | 71 | 0.063 | |
| regulation of leukocyte apoptotic process | GO:2000106 | 56 | 0.060 | |
| adaptive immune response | GO:0002250 | 155 | 0.059 | |
| ameboidal type cell migration | GO:0001667 | 128 | 0.059 | |
| adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | GO:0002460 | 145 | 0.059 | |
| peptide hormone secretion | GO:0030072 | 109 | 0.059 | |
| heterocycle catabolic process | GO:0046700 | 280 | 0.058 | |
| protein maturation | GO:0051604 | 176 | 0.058 | |
| regulation of actin filament depolymerization | GO:0030834 | 13 | 0.057 | |
| peptide transport | GO:0015833 | 133 | 0.056 | |
| negative regulation of synaptic vesicle exocytosis | GO:2000301 | 3 | 0.056 | |
| regulation of cell motility | GO:2000145 | 236 | 0.055 | |
| actin filament polymerization | GO:0030041 | 44 | 0.055 | |
| regulation of hydrolase activity | GO:0051336 | 246 | 0.055 | |
| cell adhesion | GO:0007155 | 329 | 0.055 | |
| ribonucleoside triphosphate metabolic process | GO:0009199 | 220 | 0.054 | |
| cellular amino acid metabolic process | GO:0006520 | 103 | 0.054 | |
| single organismal cell cell adhesion | GO:0016337 | 131 | 0.054 | |
| retrograde transport endosome to golgi | GO:0042147 | 2 | 0.053 | |
| actin filament depolymerization | GO:0030042 | 15 | 0.053 | |
| peptidyl tyrosine modification | GO:0018212 | 145 | 0.053 | |
| regulation of organelle organization | GO:0033043 | 289 | 0.053 | Human |
| protein localization to organelle | GO:0033365 | 185 | 0.052 | |
| endomembrane system organization | GO:0010256 | 147 | 0.052 | |
| regulation of neuron projection development | GO:0010975 | 169 | 0.051 | |
| cytokine production | GO:0001816 | 319 | 0.051 | |
| regulation of cell projection organization | GO:0031344 | 206 | 0.051 | |
| positive regulation of cell projection organization | GO:0031346 | 95 | 0.051 | |
| guanosine containing compound metabolic process | GO:1901068 | 144 | 0.051 | |
| regulation of vesicle mediated transport | GO:0060627 | 139 | 0.050 | Human |
| regulation of t cell mediated cytotoxicity | GO:0001914 | 18 | 0.050 | |
| negative regulation of molecular function | GO:0044092 | 258 | 0.050 | |
| positive regulation of neutrophil apoptotic process | GO:0033031 | 1 | 0.050 | |
| actin cytoskeleton organization | GO:0030036 | 220 | 0.049 | |
| organic acid transport | GO:0015849 | 101 | 0.049 | |
| regulation of neuron differentiation | GO:0045664 | 281 | 0.048 | |
| interleukin 8 secretion | GO:0072606 | 3 | 0.048 | |
| regulation of mapk cascade | GO:0043408 | 248 | 0.048 | |
| engulfment of apoptotic cell | GO:0043652 | 3 | 0.048 | |
| transmembrane transport | GO:0055085 | 412 | 0.048 | |
| cellularization | GO:0007349 | 1 | 0.048 | |
| vesicle localization | GO:0051648 | 86 | 0.048 | |
| t cell mediated cytotoxicity | GO:0001913 | 26 | 0.048 | |
| mapk cascade | GO:0000165 | 281 | 0.048 | |
| regulation of actin filament polymerization | GO:0030833 | 38 | 0.048 | |
| nitrogen compound transport | GO:0071705 | 271 | 0.047 | |
| positive regulation of hormone secretion | GO:0046887 | 38 | 0.047 | |
| positive regulation of cellular amino acid metabolic process | GO:0045764 | 3 | 0.047 | |
| positive regulation of organelle organization | GO:0010638 | 128 | 0.047 | Human |
| regulation of cell migration | GO:0030334 | 219 | 0.046 | |
| regulation of calcium ion dependent exocytosis | GO:0017158 | 16 | 0.046 | |
| positive regulation of mapk cascade | GO:0043410 | 170 | 0.046 | |
| protein polymerization | GO:0051258 | 57 | 0.046 | |
| positive regulation of protein modification process | GO:0031401 | 299 | 0.045 | |
| regulation of intracellular protein transport | GO:0033157 | 82 | 0.044 | |
| sensory perception of touch | GO:0050975 | 2 | 0.044 | |
| cell killing | GO:0001906 | 67 | 0.044 | |
| neural tube development | GO:0021915 | 160 | 0.044 | |
| regulation of actin filament length | GO:0030832 | 45 | 0.043 | |
| regulation of intracellular transport | GO:0032386 | 159 | 0.043 | |
| substrate dependent cell migration cell extension | GO:0006930 | 4 | 0.043 | |
| stem cell development | GO:0048864 | 219 | 0.042 | |
| negative regulation of protein depolymerization | GO:1901880 | 21 | 0.042 | |
| t cell apoptotic process | GO:0070231 | 39 | 0.042 | |
| regulation of cellular component size | GO:0032535 | 121 | 0.042 | |
| regulation of neurotransmitter levels | GO:0001505 | 87 | 0.042 | |
| positive regulation of insulin secretion | GO:0032024 | 26 | 0.042 | |
| actin cytoskeleton reorganization | GO:0031532 | 21 | 0.041 | |
| regulation of angiotensin metabolic process | GO:0060177 | 4 | 0.040 | |
| regulation of protein complex assembly | GO:0043254 | 83 | 0.040 | |
| microtubule based process | GO:0007017 | 236 | 0.040 | |
| nucleoside catabolic process | GO:0009164 | 206 | 0.039 | |
| sequestering of metal ion | GO:0051238 | 19 | 0.039 | |
| regulation of wnt signaling pathway | GO:0030111 | 123 | 0.039 | |
| regulation of actin filament based process | GO:0032970 | 99 | 0.039 | |
| ribonucleoside metabolic process | GO:0009119 | 245 | 0.038 | |
| submandibular salivary gland formation | GO:0060661 | 1 | 0.038 | |
| exocyst localization | GO:0051601 | 2 | 0.038 | |
| regulation of response to wounding | GO:1903034 | 189 | 0.038 | |
| ribonucleoside catabolic process | GO:0042454 | 206 | 0.038 | |
| positive regulation of apoptotic process | GO:0043065 | 217 | 0.037 | |
| oocyte construction | GO:0007308 | 2 | 0.037 | |
| inflammatory response | GO:0006954 | 244 | 0.037 | |
| cell type specific apoptotic process | GO:0097285 | 268 | 0.037 | |
| maintenance of location | GO:0051235 | 89 | 0.036 | |
| positive regulation of cell development | GO:0010720 | 237 | 0.036 | |
| stem cell differentiation | GO:0048863 | 268 | 0.036 | |
| ribose phosphate metabolic process | GO:0019693 | 291 | 0.035 | |
| anion transport | GO:0006820 | 177 | 0.035 | |
| skin development | GO:0043588 | 220 | 0.035 | |
| morphogenesis of embryonic epithelium | GO:0016331 | 159 | 0.034 | |
| positive regulation of nervous system development | GO:0051962 | 221 | 0.034 | |
| protein import into nucleus | GO:0006606 | 95 | 0.034 | |
| cellular ketone metabolic process | GO:0042180 | 84 | 0.034 | |
| wnt signaling pathway | GO:0016055 | 188 | 0.034 | |
| negative regulation of neurotransmitter secretion | GO:0046929 | 5 | 0.034 | |
| neurotransmitter transport | GO:0006836 | 76 | 0.033 | |
| epithelial tube morphogenesis | GO:0060562 | 303 | 0.033 | |
| cell activation involved in immune response | GO:0002263 | 126 | 0.032 | |
| response to organonitrogen compound | GO:0010243 | 246 | 0.032 | |
| regulation of interleukin 8 secretion | GO:2000482 | 2 | 0.032 | |
| positive regulation of vasculogenesis | GO:2001214 | 7 | 0.032 | |
| regulation of peptide hormone secretion | GO:0090276 | 75 | 0.032 | |
| morphogenesis of a polarized epithelium | GO:0001738 | 37 | 0.031 | |
| cellular response to hormone stimulus | GO:0032870 | 150 | 0.031 | |
| establishment or maintenance of cell polarity | GO:0007163 | 86 | 0.031 | |
| protein targeting to vacuole | GO:0006623 | 3 | 0.031 | |
| cation homeostasis | GO:0055080 | 212 | 0.031 | |
| positive regulation of cysteine type endopeptidase activity involved in apoptotic process | GO:0043280 | 36 | 0.031 | |
| positive regulation of lamellipodium assembly | GO:0010592 | 2 | 0.031 | |
| substrate dependent cell migration | GO:0006929 | 18 | 0.030 | |
| organic anion transport | GO:0015711 | 137 | 0.030 | |
| endoplasmic reticulum tubular network organization | GO:0071786 | 1 | 0.030 | |
| regulation of synaptic vesicle exocytosis | GO:2000300 | 11 | 0.030 | |
| negative regulation of interleukin 8 secretion | GO:2000483 | 1 | 0.030 | |
| apoptotic signaling pathway | GO:0097190 | 306 | 0.030 | |
| defense response to other organism | GO:0098542 | 197 | 0.029 | |
| protein complex disassembly | GO:0043241 | 40 | 0.029 | |
| regulation of protein depolymerization | GO:1901879 | 26 | 0.029 | |
| cellular metal ion homeostasis | GO:0006875 | 151 | 0.029 | |
| circulatory system process | GO:0003013 | 197 | 0.029 | |
| regulation of endopeptidase activity | GO:0052548 | 89 | 0.029 | |
| regulation of cell activation | GO:0050865 | 289 | 0.029 | |
| interleukin 8 production | GO:0032637 | 4 | 0.029 | |
| epithelium migration | GO:0090132 | 63 | 0.029 | |
| transforming growth factor beta1 production | GO:0032905 | 3 | 0.028 | |
| developmental maturation | GO:0021700 | 193 | 0.028 | |
| hair follicle cell proliferation | GO:0071335 | 3 | 0.028 | |
| purine nucleoside catabolic process | GO:0006152 | 205 | 0.028 | |
| intrahepatic bile duct development | GO:0035622 | 2 | 0.028 | |
| microtubule cytoskeleton organization | GO:0000226 | 157 | 0.028 | |
| purine nucleotide metabolic process | GO:0006163 | 302 | 0.028 | |
| positive regulation of protein phosphorylation | GO:0001934 | 242 | 0.028 | |
| protein targeting | GO:0006605 | 143 | 0.028 | |
| adherens junction organization | GO:0034332 | 28 | 0.027 | |
| regulation of clathrin mediated endocytosis | GO:2000369 | 4 | 0.027 | |
| regulation of lymphocyte activation | GO:0051249 | 240 | 0.027 | |
| neural tube formation | GO:0001841 | 108 | 0.027 | |
| lipid transport | GO:0006869 | 98 | 0.027 | |
| regulation of hair follicle cell proliferation | GO:0071336 | 2 | 0.027 | |
| regulation of synaptic growth at neuromuscular junction | GO:0008582 | 4 | 0.027 | |
| tissue migration | GO:0090130 | 68 | 0.027 | |
| regulation of adaptive immune response | GO:0002819 | 90 | 0.027 | |
| spermatogenesis | GO:0007283 | 284 | 0.026 | |
| granzyme mediated apoptotic signaling pathway | GO:0008626 | 1 | 0.026 | |
| maintenance of location in cell | GO:0051651 | 24 | 0.026 | |
| neural precursor cell proliferation | GO:0061351 | 121 | 0.026 | |
| regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | GO:0002822 | 87 | 0.026 | |
| regulation of protein targeting | GO:1903533 | 61 | 0.026 | |
| ribonucleotide metabolic process | GO:0009259 | 291 | 0.026 | |
| regulation of interleukin 8 production | GO:0032677 | 3 | 0.026 | |
| purine ribonucleotide metabolic process | GO:0009150 | 290 | 0.026 | |
| cytoskeleton dependent intracellular transport | GO:0030705 | 50 | 0.025 | |
| regulated secretory pathway | GO:0045055 | 32 | 0.025 | |
| cell cell junction organization | GO:0045216 | 72 | 0.025 | |
| cellular response to lipid | GO:0071396 | 145 | 0.025 | |
| cellular homeostasis | GO:0019725 | 240 | 0.025 | |
| carbohydrate homeostasis | GO:0033500 | 128 | 0.025 | |
| regulation of synaptic vesicle transport | GO:1902803 | 13 | 0.025 | |
| pigment metabolic process | GO:0042440 | 32 | 0.025 | |
| rho protein signal transduction | GO:0007266 | 32 | 0.024 | |
| epithelial tube formation | GO:0072175 | 130 | 0.024 | |
| regulation of anatomical structure size | GO:0090066 | 178 | 0.024 | |
| regulation of cytokine production | GO:0001817 | 266 | 0.024 | |
| cellular response to monosaccharide stimulus | GO:0071326 | 47 | 0.024 | |
| microtubule based transport | GO:0010970 | 50 | 0.024 | |
| central nervous system neuron differentiation | GO:0021953 | 162 | 0.024 | |
| hormone metabolic process | GO:0042445 | 86 | 0.024 | |
| cellular chemical homeostasis | GO:0055082 | 215 | 0.024 | |
| peptidyl amino acid modification | GO:0018193 | 336 | 0.024 | |
| positive regulation of cytokine production | GO:0001819 | 174 | 0.024 | |
| regulation of cellular component biogenesis | GO:0044087 | 181 | 0.023 | Human |
| positive regulation of apoptotic signaling pathway | GO:2001235 | 95 | 0.023 | |
| insulin secretion involved in cellular response to glucose stimulus | GO:0035773 | 36 | 0.023 | |
| carbohydrate derivative catabolic process | GO:1901136 | 231 | 0.023 | |
| synaptic vesicle exocytosis | GO:0016079 | 26 | 0.023 | |
| regulation of establishment of planar polarity | GO:0090175 | 28 | 0.023 | |
| germ cell development | GO:0007281 | 185 | 0.023 | |
| positive regulation of hydrolase activity | GO:0051345 | 148 | 0.023 | |
| cellular response to molecule of bacterial origin | GO:0071219 | 83 | 0.023 | |
| carboxylic acid transport | GO:0046942 | 100 | 0.023 | |
| purine ribonucleoside monophosphate metabolic process | GO:0009167 | 80 | 0.023 | |
| protein localization to vacuole | GO:0072665 | 4 | 0.023 | |
| negative regulation of protein transport | GO:0051224 | 46 | 0.023 | |
| positive regulation of homeostatic process | GO:0032846 | 64 | 0.023 | |
| inorganic cation transmembrane transport | GO:0098662 | 207 | 0.022 | |
| regulation of nucleoside metabolic process | GO:0009118 | 130 | 0.022 | |
| neutrophil degranulation | GO:0043312 | 6 | 0.022 | |
| meiotic cell cycle | GO:0051321 | 122 | 0.022 | |
| cellular amide metabolic process | GO:0043603 | 58 | 0.022 | |
| posttranscriptional regulation of gene expression | GO:0010608 | 155 | 0.022 | |
| leukocyte homeostasis | GO:0001776 | 79 | 0.022 | |
| negative regulation of oxidative stress induced intrinsic apoptotic signaling pathway | GO:1902176 | 4 | 0.022 | |
| myeloid leukocyte activation | GO:0002274 | 83 | 0.022 | |
| regulation of organ morphogenesis | GO:2000027 | 144 | 0.022 | |
| regulation of synapse structural plasticity | GO:0051823 | 4 | 0.022 | |
| fatty acid derivative transport | GO:1901571 | 14 | 0.022 | |
| regulation of multi organism process | GO:0043900 | 111 | 0.022 | |
| positive regulation of secretion | GO:0051047 | 130 | 0.021 | Human |
| ras protein signal transduction | GO:0007265 | 77 | 0.021 | |
| positive regulation of cell motility | GO:2000147 | 116 | 0.021 | |
| fibrinolysis | GO:0042730 | 3 | 0.021 | |
| g protein coupled receptor signaling pathway | GO:0007186 | 243 | 0.021 | |
| protein localization involved in establishment of planar polarity | GO:0090251 | 1 | 0.021 | |
| positive regulation of immune effector process | GO:0002699 | 107 | 0.021 | |
| cellular response to organonitrogen compound | GO:0071417 | 145 | 0.021 | |
| regulation of leukocyte mediated cytotoxicity | GO:0001910 | 38 | 0.021 | |
| positive regulation of growth | GO:0045927 | 104 | 0.021 | |
| regulation of membrane potential | GO:0042391 | 192 | 0.020 | |
| regionalization | GO:0003002 | 337 | 0.020 | |
| regulation of vasculature development | GO:1901342 | 88 | 0.020 | |
| tissue remodeling | GO:0048771 | 102 | 0.020 | |
| regulation of neutrophil apoptotic process | GO:0033029 | 1 | 0.020 | |
| regulation of proteolysis | GO:0030162 | 164 | 0.020 | |
| regulation of cell morphogenesis involved in differentiation | GO:0010769 | 151 | 0.020 | |
| organic cyclic compound catabolic process | GO:1901361 | 295 | 0.020 | |
| transmission of nerve impulse | GO:0019226 | 76 | 0.020 | |
| nucleoside monophosphate catabolic process | GO:0009125 | 59 | 0.020 | |
| regulation of protein autophosphorylation | GO:0031952 | 8 | 0.020 | |
| leukocyte differentiation | GO:0002521 | 342 | 0.020 | |
| regulation of protein catabolic process | GO:0042176 | 108 | 0.019 | |
| cellular response to hexose stimulus | GO:0071331 | 47 | 0.019 | |
| peptide metabolic process | GO:0006518 | 46 | 0.019 | |
| regulation of peptide transport | GO:0090087 | 91 | 0.019 | |
| embryonic epithelial tube formation | GO:0001838 | 130 | 0.019 | |
| negative regulation of hydrolase activity | GO:0051346 | 71 | 0.019 | |
| ion transmembrane transport | GO:0034220 | 361 | 0.019 | |
| lamellipodium organization | GO:0097581 | 29 | 0.019 | |
| eye pigmentation | GO:0048069 | 3 | 0.019 | |
| establishment of planar polarity | GO:0001736 | 28 | 0.019 | |
| calcium ion transport | GO:0006816 | 159 | 0.019 | |
| positive regulation of wnt signaling pathway | GO:0030177 | 45 | 0.019 | |
| l amino acid transport | GO:0015807 | 32 | 0.018 | |
| wound healing | GO:0042060 | 157 | 0.018 | |
| nucleoside triphosphate catabolic process | GO:0009143 | 205 | 0.018 | |
| cytokine secretion | GO:0050663 | 72 | 0.018 | |
| virion assembly | GO:0019068 | 1 | 0.018 | |
| regulation of cytoplasmic transport | GO:1903649 | 112 | 0.018 | |
| divalent metal ion transport | GO:0070838 | 172 | 0.018 | |
| establishment or maintenance of microtubule cytoskeleton polarity | GO:0030951 | 1 | 0.018 | |
| protein localization to nucleus | GO:0034504 | 121 | 0.018 | |
| regulation of cell killing | GO:0031341 | 40 | 0.018 | |
| regulation of kinase activity | GO:0043549 | 249 | 0.018 | |
| regulation of cellular catabolic process | GO:0031329 | 242 | 0.018 | |
| regulation of peptidase activity | GO:0052547 | 96 | 0.017 | |
| olfactory bulb interneuron differentiation | GO:0021889 | 12 | 0.017 | |
| positive regulation of cellular component biogenesis | GO:0044089 | 94 | 0.017 | Human |
| regulation of protein maturation | GO:1903317 | 96 | 0.017 | |
| organic hydroxy compound metabolic process | GO:1901615 | 203 | 0.017 | |
| regulation of peptide secretion | GO:0002791 | 77 | 0.017 | |
| somite development | GO:0061053 | 81 | 0.017 | |
| stem cell maintenance | GO:0019827 | 130 | 0.017 | |
| epidermis development | GO:0008544 | 187 | 0.017 | |
| cellular ion homeostasis | GO:0006873 | 165 | 0.017 | |
| multicellular organismal signaling | GO:0035637 | 91 | 0.017 | |
| positive regulation of lamellipodium organization | GO:1902745 | 3 | 0.016 | |
| protein localization to plasma membrane | GO:0072659 | 57 | 0.016 | |
| neutrophil chemotaxis | GO:0030593 | 36 | 0.016 | |
| myelination | GO:0042552 | 74 | 0.016 | |
| regulation of hormone secretion | GO:0046883 | 88 | 0.016 | |
| gtp metabolic process | GO:0046039 | 144 | 0.016 | |
| receptor recycling | GO:0001881 | 11 | 0.016 | |
| peptidyl tyrosine phosphorylation | GO:0018108 | 143 | 0.016 | |
| regulation of protein complex disassembly | GO:0043244 | 28 | 0.016 | |
| response to peptide hormone | GO:0043434 | 127 | 0.016 | |
| regulation of peptidyl tyrosine phosphorylation | GO:0050730 | 93 | 0.016 | |
| positive regulation of neuron differentiation | GO:0045666 | 141 | 0.016 | |
| vesicle organization | GO:0016050 | 60 | 0.016 | Human |
| icosanoid secretion | GO:0032309 | 12 | 0.016 | |
| positive regulation of nucleotide catabolic process | GO:0030813 | 88 | 0.016 | |
| negative regulation of cell proliferation | GO:0008285 | 296 | 0.016 | |
| phospholipid metabolic process | GO:0006644 | 87 | 0.016 | |
| cell fate determination involved in pattern specification | GO:0060582 | 1 | 0.016 | |
| blood circulation | GO:0008015 | 195 | 0.016 | |
| positive regulation of hair follicle cell proliferation | GO:0071338 | 1 | 0.015 | |
| cellular response to organic cyclic compound | GO:0071407 | 87 | 0.015 | |
| regulation of vasculogenesis | GO:2001212 | 9 | 0.015 | |
| protein import | GO:0017038 | 101 | 0.015 | |
| ribonucleoside monophosphate metabolic process | GO:0009161 | 80 | 0.015 | |
| establishment of endothelial blood brain barrier | GO:0014045 | 3 | 0.015 | |
| t cell differentiation | GO:0030217 | 174 | 0.015 | |
| negative regulation of actin filament polymerization | GO:0030837 | 11 | 0.015 | |
| leukocyte activation involved in immune response | GO:0002366 | 126 | 0.015 | |
| regulation of acute inflammatory response | GO:0002673 | 27 | 0.015 | |
| vacuolar transport | GO:0007034 | 11 | 0.015 | |
| regulation of substrate adhesion dependent cell spreading | GO:1900024 | 12 | 0.015 | |
| endocytosis | GO:0006897 | 168 | 0.015 | |
| asymmetric stem cell division | GO:0098722 | 3 | 0.015 | |
| chromosome movement towards spindle pole | GO:0051305 | 3 | 0.015 | |
| cytosolic calcium ion homeostasis | GO:0051480 | 70 | 0.015 | |
| compound eye development | GO:0048749 | 1 | 0.015 | |
| negative regulation of phosphate metabolic process | GO:0045936 | 184 | 0.015 | |
| leukocyte mediated cytotoxicity | GO:0001909 | 62 | 0.015 | |
| sterol transport | GO:0015918 | 38 | 0.015 | |
| single organism nuclear import | GO:1902593 | 95 | 0.015 | |
| positive regulation of tumor necrosis factor ligand superfamily member 11 production | GO:2000309 | 1 | 0.015 | |
| axon target recognition | GO:0007412 | 4 | 0.015 | |
| regulation of fibrinolysis | GO:0051917 | 1 | 0.015 | |
| tissue homeostasis | GO:0001894 | 115 | 0.015 | |
| male gamete generation | GO:0048232 | 285 | 0.015 | |
| somitogenesis | GO:0001756 | 69 | 0.015 | |
| negative regulation of t cell activation | GO:0050868 | 65 | 0.015 | |
| purine nucleotide catabolic process | GO:0006195 | 211 | 0.015 | |
| negative regulation of intracellular transport | GO:0032387 | 38 | 0.015 | |
| positive regulation of lymphocyte activation | GO:0051251 | 140 | 0.015 | |
| lymphocyte apoptotic process | GO:0070227 | 54 | 0.015 | |
| endothelial cell development | GO:0001885 | 20 | 0.015 | |
| activation of mapk activity | GO:0000187 | 59 | 0.014 | |
| regulation of apoptotic signaling pathway | GO:2001233 | 197 | 0.014 | |
| organic hydroxy compound transport | GO:0015850 | 93 | 0.014 | |
| positive regulation of cell migration | GO:0030335 | 109 | 0.014 | |
| neuronal action potential | GO:0019228 | 54 | 0.014 | |
| negative regulation of binding | GO:0051100 | 39 | 0.014 | |
| regulation of t cell activation | GO:0050863 | 170 | 0.014 | |
| response to molecule of bacterial origin | GO:0002237 | 143 | 0.014 | |
| positive regulation of response to wounding | GO:1903036 | 66 | 0.014 | |
| rac protein signal transduction | GO:0016601 | 13 | 0.014 | |
| actin filament capping | GO:0051693 | 6 | 0.014 | |
| adult locomotory behavior | GO:0008344 | 91 | 0.014 | |
| positive regulation of leukocyte mediated cytotoxicity | GO:0001912 | 31 | 0.014 | |
| protein depolymerization | GO:0051261 | 34 | 0.014 | |
| regulation of cell growth | GO:0001558 | 91 | 0.014 | |
| sperm individualization | GO:0007291 | 1 | 0.014 | |
| positive regulation of myeloid cell apoptotic process | GO:0033034 | 4 | 0.014 | |
| myeloid cell differentiation | GO:0030099 | 233 | 0.014 | |
| positive regulation of t cell mediated immunity | GO:0002711 | 24 | 0.014 | |
| granulocyte migration | GO:0097530 | 43 | 0.014 | |
| positive regulation of synaptic growth at neuromuscular junction | GO:0045887 | 1 | 0.014 | |
| phagolysosome assembly | GO:0001845 | 3 | 0.014 | |
| positive regulation of transforming growth factor beta1 production | GO:0032914 | 2 | 0.014 | |
| defense response to bacterium | GO:0042742 | 119 | 0.014 | |
| positive regulation of protein complex assembly | GO:0031334 | 45 | 0.014 | |
| regulation of neuron death | GO:1901214 | 134 | 0.014 | |
| bone remodeling | GO:0046849 | 53 | 0.013 | |
| muscle contraction | GO:0006936 | 101 | 0.013 | |
| response to inorganic substance | GO:0010035 | 96 | 0.013 | |
| mesenchymal cell differentiation | GO:0048762 | 107 | 0.013 | |
| organonitrogen compound biosynthetic process | GO:1901566 | 192 | 0.013 | |
| dna metabolic process | GO:0006259 | 303 | 0.013 | |
| macromolecular complex disassembly | GO:0032984 | 43 | 0.013 | |
| regulation of neural precursor cell proliferation | GO:2000177 | 70 | 0.013 | |
| morphogenesis of an epithelial fold | GO:0060571 | 28 | 0.013 | |
| digestive system development | GO:0055123 | 200 | 0.013 | |
| inorganic ion transmembrane transport | GO:0098660 | 234 | 0.013 | |
| response to organic cyclic compound | GO:0014070 | 198 | 0.013 | |
| glial cell differentiation | GO:0010001 | 131 | 0.013 | |
| amino acid transport | GO:0006865 | 61 | 0.013 | |
| response to endoplasmic reticulum stress | GO:0034976 | 53 | 0.013 | |
| notch signaling pathway | GO:0007219 | 71 | 0.013 | |
| neural tube patterning | GO:0021532 | 43 | 0.013 | |
| regulation of cellular response to stress | GO:0080135 | 159 | 0.013 | |
| regulation of nucleotide metabolic process | GO:0006140 | 169 | 0.013 | |
| lipid localization | GO:0010876 | 126 | 0.013 | |
| alpha beta t cell differentiation | GO:0046632 | 69 | 0.013 | |
| carbohydrate derivative biosynthetic process | GO:1901137 | 183 | 0.013 | |
| positive regulation of map kinase activity | GO:0043406 | 84 | 0.013 | |
| oogenesis | GO:0048477 | 56 | 0.013 | |
| regulation of cellular response to growth factor stimulus | GO:0090287 | 82 | 0.013 | |
| central nervous system morphogenesis | GO:0021551 | 2 | 0.013 | |
| rab protein signal transduction | GO:0032482 | 1 | 0.012 | |
| response to acid chemical | GO:0001101 | 111 | 0.012 | |
| response to monosaccharide | GO:0034284 | 67 | 0.012 | |
| cellular divalent inorganic cation homeostasis | GO:0072503 | 127 | 0.012 | |
| small gtpase mediated signal transduction | GO:0007264 | 97 | 0.012 | |
| acute inflammatory response | GO:0002526 | 41 | 0.012 | |
| negative regulation of neuron death | GO:1901215 | 98 | 0.012 | |
| regulation of t cell proliferation | GO:0042129 | 92 | 0.012 | |
| positive regulation of synapse structural plasticity | GO:0051835 | 1 | 0.012 | |
| regulation of transferase activity | GO:0051338 | 263 | 0.012 | |
| muscle system process | GO:0003012 | 141 | 0.012 | |
| spermatid development | GO:0007286 | 108 | 0.012 | |
| regulation of sequence specific dna binding transcription factor activity | GO:0051090 | 106 | 0.012 | |
| sequestering of calcium ion | GO:0051208 | 18 | 0.012 | |
| hemostasis | GO:0007599 | 78 | 0.012 | |
| epithelial cell development | GO:0002064 | 159 | 0.012 | |
| phenol containing compound metabolic process | GO:0018958 | 60 | 0.012 | |
| epidermis morphogenesis | GO:0048730 | 33 | 0.012 | |
| guanosine containing compound catabolic process | GO:1901069 | 144 | 0.012 | |
| regulation of systemic arterial blood pressure mediated by a chemical signal | GO:0003044 | 33 | 0.012 | |
| anatomical structure homeostasis | GO:0060249 | 145 | 0.012 | |
| positive regulation of protein kinase activity | GO:0045860 | 144 | 0.012 | |
| positive regulation of cell activation | GO:0050867 | 158 | 0.012 | |
| cellular glucose homeostasis | GO:0001678 | 52 | 0.012 | |
| sensory perception | GO:0007600 | 245 | 0.012 | |
| multi multicellular organism process | GO:0044706 | 109 | 0.012 | |
